Cargando…
Mechanisms of AMPA Receptor Inhibition by Diminazene
Diminazene is an anti-infection agent for animals and is a member of the diarylamidine group. This study reports the first detection of its inhibitory effect on AMPA-type ionotropic glutamate receptors. Experiments were carried out on isolated Wistar rat neurons: striatal giant cholinergic interneur...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8930484/ https://www.ncbi.nlm.nih.gov/pubmed/35317269 http://dx.doi.org/10.1007/s11055-022-01238-y |
_version_ | 1784671070381408256 |
---|---|
author | Zhigulin, A. S. Dron, M. Yu. Barygin, O. I. |
author_facet | Zhigulin, A. S. Dron, M. Yu. Barygin, O. I. |
author_sort | Zhigulin, A. S. |
collection | PubMed |
description | Diminazene is an anti-infection agent for animals and is a member of the diarylamidine group. This study reports the first detection of its inhibitory effect on AMPA-type ionotropic glutamate receptors. Experiments were carried out on isolated Wistar rat neurons: striatal giant cholinergic interneurons were used to study calcium-permeable AMPA receptors and hippocampal field CA1 pyramidal neurons were used to study calcium-impermeable AMPA receptors. Cells were isolated by vibrodissociation and currents were recorded by voltage clamping in the whole cell configuration. Diminazene produced concentration-dependent inhibition of currents evoked by application of kainate in both neuron types. IC(50) values for calcium-permeable and calcium-impermeable AMPA receptors were 60 ± 11 and 160 ± 30 μM, respectively. Of note is that the inhibitory action of diminazene increased with increases in agonist concentration. The plot of the voltage dependence of inhibition at a fixed diminazene concentration for calcium-permeable AMPA receptors was biphasic: minimal inhibition was seen at positive potentials and maximum at –40 to –60 mV, while further hyperpolarization produced a gradual decrease in blockade efficacy. All these properties provide evidence that diminazene blocks AMPA receptor channels, perhaps with penetration through channels into cells. |
format | Online Article Text |
id | pubmed-8930484 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Springer International Publishing |
record_format | MEDLINE/PubMed |
spelling | pubmed-89304842022-03-18 Mechanisms of AMPA Receptor Inhibition by Diminazene Zhigulin, A. S. Dron, M. Yu. Barygin, O. I. Neurosci Behav Physiol Article Diminazene is an anti-infection agent for animals and is a member of the diarylamidine group. This study reports the first detection of its inhibitory effect on AMPA-type ionotropic glutamate receptors. Experiments were carried out on isolated Wistar rat neurons: striatal giant cholinergic interneurons were used to study calcium-permeable AMPA receptors and hippocampal field CA1 pyramidal neurons were used to study calcium-impermeable AMPA receptors. Cells were isolated by vibrodissociation and currents were recorded by voltage clamping in the whole cell configuration. Diminazene produced concentration-dependent inhibition of currents evoked by application of kainate in both neuron types. IC(50) values for calcium-permeable and calcium-impermeable AMPA receptors were 60 ± 11 and 160 ± 30 μM, respectively. Of note is that the inhibitory action of diminazene increased with increases in agonist concentration. The plot of the voltage dependence of inhibition at a fixed diminazene concentration for calcium-permeable AMPA receptors was biphasic: minimal inhibition was seen at positive potentials and maximum at –40 to –60 mV, while further hyperpolarization produced a gradual decrease in blockade efficacy. All these properties provide evidence that diminazene blocks AMPA receptor channels, perhaps with penetration through channels into cells. Springer International Publishing 2022-03-18 2022 /pmc/articles/PMC8930484/ /pubmed/35317269 http://dx.doi.org/10.1007/s11055-022-01238-y Text en © Springer Nature Switzerland AG 2022 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic. |
spellingShingle | Article Zhigulin, A. S. Dron, M. Yu. Barygin, O. I. Mechanisms of AMPA Receptor Inhibition by Diminazene |
title | Mechanisms of AMPA Receptor Inhibition by Diminazene |
title_full | Mechanisms of AMPA Receptor Inhibition by Diminazene |
title_fullStr | Mechanisms of AMPA Receptor Inhibition by Diminazene |
title_full_unstemmed | Mechanisms of AMPA Receptor Inhibition by Diminazene |
title_short | Mechanisms of AMPA Receptor Inhibition by Diminazene |
title_sort | mechanisms of ampa receptor inhibition by diminazene |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8930484/ https://www.ncbi.nlm.nih.gov/pubmed/35317269 http://dx.doi.org/10.1007/s11055-022-01238-y |
work_keys_str_mv | AT zhigulinas mechanismsofampareceptorinhibitionbydiminazene AT dronmyu mechanismsofampareceptorinhibitionbydiminazene AT baryginoi mechanismsofampareceptorinhibitionbydiminazene |